Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs
2023-12-26 17:26
PharmaBlock Obtained ISO 50001 Certification, Advancing Sustainable Development
2023-12-26 11:00
Harbin City Pushes for Breakthroughs in Full Revitalization of Northeast China
2023-12-25 20:42
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
2023-12-25 10:15
APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia
2023-12-24 17:53
GenSci Launches Global Innovation Hub in Shanghai
2023-12-23 15:41
Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results
2023-12-22 19:00
TransThera Announces the Global Multicenter Phase 3 Clinical Trial Completed First Patient Dosing in the US Evaluating Tinengotinib in FGFRi Relapsed/Refractory Patients with Cholangiocarcinoma
2023-12-21 21:45
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial
2023-12-21 08:26
YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting
2023-12-21 05:30
/DISREGARD RELEASE: YS Biopharma/
2023-12-21 05:15
CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors
2023-12-21 01:00
Genevoyager Unveils Gene Therapy CDMO Facility in Milestone Move
2023-12-20 23:10
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum
2023-12-20 20:00
InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs
2023-12-20 09:00
Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case
2023-12-19 22:00
New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA
2023-12-19 20:00
Tianjin's Youthful Energy Sparks Citywide Revival
2023-12-19 15:44
Biorithm Secures $3.5 Million in Series A Funding to Advance Maternal Care Worldwide
2023-12-18 22:00
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
2023-12-18 19:00
1
56
57
58
59
60
800